Barclays’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Barclays’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-115	Closed	–	–	7997
2014 Q2	$0	Hold	115	–	–	﹤0.01%	7978
2014 Q1	$0	Sell	115 -300	-72%	-$506	﹤0.01%	7866
2013 Q4	$0	Buy	+415	New	+$935	﹤0.01%	7844

Other funds holding ONCY

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

RFC

Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

VFS

VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Barclays's ONCY Position: Q3 2014 in Review

Barclays sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q3 2014, closing a stake of 115 shares.

Barclays first reported a position in ONCY in Q4 2013 and held it in 3 quarters. The position peaked at $0 in Q2 2014. 30 funds tracked by Wall St. Rank hold ONCY as of Q3 2014.

Barclays reported no remaining ONCOLYTICS BIOTECH INC position as of Q3 2014 after selling out during the quarter.
Barclays sold 115 ONCOLYTICS BIOTECH INC shares in Q3 2014.
Barclays first reported a position in ONCOLYTICS BIOTECH INC in Q4 2013 and held it in 3 quarters.
Barclays's ONCOLYTICS BIOTECH INC position peaked at $0 in Q2 2014.
30 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q3 2014.

Based on Barclays's 13F filing for Q3 2014, filed 14 Nov 2014.